FREGA, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 2.093
AS - Asia 1.447
EU - Europa 603
SA - Sud America 199
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 19
Totale 4.596
Nazione #
US - Stati Uniti d'America 1.983
VN - Vietnam 404
SG - Singapore 378
CN - Cina 246
IT - Italia 137
BR - Brasile 129
HK - Hong Kong 111
DE - Germania 58
IN - India 52
GB - Regno Unito 50
SE - Svezia 47
FR - Francia 44
BD - Bangladesh 43
FI - Finlandia 42
CA - Canada 37
PL - Polonia 37
TR - Turchia 31
NL - Olanda 23
RU - Federazione Russa 23
IQ - Iraq 22
AR - Argentina 17
JP - Giappone 13
UZ - Uzbekistan 13
AO - Angola 12
ID - Indonesia 12
TN - Tunisia 12
AT - Austria 11
MX - Messico 11
KR - Corea 10
MD - Moldavia 10
ZA - Sudafrica 10
DZ - Algeria 9
EC - Ecuador 9
ES - Italia 9
PK - Pakistan 9
SA - Arabia Saudita 9
VE - Venezuela 9
CL - Cile 8
CR - Costa Rica 8
GE - Georgia 8
IE - Irlanda 8
PY - Paraguay 8
RO - Romania 8
RS - Serbia 8
UA - Ucraina 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
JO - Giordania 7
LY - Libia 7
NE - Niger 7
PH - Filippine 7
XK - ???statistics.table.value.countryCode.XK??? 7
BA - Bosnia-Erzegovina 6
CH - Svizzera 6
CU - Cuba 6
DJ - Gibuti 6
GN - Guinea 6
KE - Kenya 6
ME - Montenegro 6
MZ - Mozambico 6
PE - Perù 6
PR - Porto Rico 6
RE - Reunion 6
SD - Sudan 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
BJ - Benin 5
BZ - Belize 5
CM - Camerun 5
CO - Colombia 5
DK - Danimarca 5
ET - Etiopia 5
GA - Gabon 5
LT - Lituania 5
MA - Marocco 5
MR - Mauritania 5
NG - Nigeria 5
PF - Polinesia Francese 5
AM - Armenia 4
AZ - Azerbaigian 4
CV - Capo Verde 4
CW - ???statistics.table.value.countryCode.CW??? 4
CY - Cipro 4
EG - Egitto 4
GF - Guiana Francese 4
GH - Ghana 4
GM - Gambi 4
GP - Guadalupe 4
GR - Grecia 4
HU - Ungheria 4
KH - Cambogia 4
LA - Repubblica Popolare Democratica del Laos 4
NC - Nuova Caledonia 4
NO - Norvegia 4
PS - Palestinian Territory 4
RW - Ruanda 4
TJ - Tagikistan 4
ZM - Zambia 4
AD - Andorra 3
Totale 4.426
Città #
Ashburn 291
Singapore 228
Fairfield 204
San Jose 164
Woodbridge 134
Ho Chi Minh City 127
Chandler 125
Hanoi 95
Hong Kong 94
Cambridge 93
Houston 83
Seattle 78
Wilmington 72
Beijing 61
Santa Clara 57
Los Angeles 40
Ann Arbor 38
New York 35
Boardman 29
Chicago 29
Helsinki 29
Da Nang 27
Padova 27
San Diego 26
Bytom 24
Council Bluffs 23
Medford 18
Princeton 18
Haiphong 17
London 16
Milan 16
Istanbul 15
Buffalo 14
Dong Ket 14
Lauterbourg 14
São Paulo 14
Des Moines 12
Montreal 12
Munich 12
Tashkent 12
Chennai 11
Luanda 11
Roxbury 11
Tokyo 11
Warsaw 11
Nuremberg 10
Columbus 9
Hefei 9
Ogden 8
Orem 8
Pune 8
Rome 8
Stockholm 8
Amman 7
Baghdad 7
Dallas 7
Nanjing 7
Phủ Lý 7
Rio de Janeiro 7
Seoul 7
Thái Nguyên 7
Tianjin 7
Ankara 6
Charlotte 6
Conakry 6
Djibouti 6
Dublin 6
Frankfurt am Main 6
Manchester 6
Nairobi 6
Niamey 6
Podgorica 6
Tbilisi 6
Washington 6
Amsterdam 5
Chisinau 5
Cotonou 5
Falkenstein 5
Guangzhou 5
Havana 5
Johannesburg 5
Lahore 5
Libreville 5
Maputo 5
Nha Trang 5
Nouakchott 5
Papeete 5
San José 5
Accra 4
Addis Ababa 4
Baku 4
Belgrade 4
Boston 4
Caracas 4
Cayenne 4
Dearborn 4
Dushanbe 4
Elk Grove Village 4
Figino 4
Hai Bà Trưng 4
Totale 2.813
Nome #
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study) 369
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature 283
A triple rare E709K and L833V/H835L EGFR mutation responsive to an irreversible pan-HER inhibitor: A case report of lung adenocarcinoma treated with afatinib 282
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 273
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 273
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 272
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 268
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 255
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 254
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 251
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 251
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 247
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 247
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future? 224
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 208
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 200
Squamous cell carcinomas of the lung and of the head and neck: New insights on molecular characterization 198
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 134
null 107
Totale 4.596
Categoria #
all - tutte 13.488
article - articoli 13.488
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 0 45 40 16 26 43 49 21 13 10 30 61
2022/2023245 39 39 7 32 26 20 2 16 39 8 16 1
2023/2024228 15 17 32 21 25 61 14 9 12 5 7 10
2024/2025564 3 25 30 32 86 15 13 49 51 16 99 145
2025/20262.381 115 197 254 341 184 103 507 156 256 148 68 52
2026/2027148 79 69 0 0 0 0 0 0 0 0 0 0
Totale 4.596